The CRISPR/Cas9 system is a powerful tool for elucidating the roles of genes in a wide variety of organisms including mice. To obtain genetically modified embryos or mice by this method, Cas9 mRNA and sgRNA are usually introduced into zygotes by microinjection or electroporation. However, most mutants generated with this method are genetically mosaic, composed of several types of cells carrying different mutations, which complicates phenotype analysis in founder embryos or mice. To simplify the analysis and to elucidate the roles of genes involved in developmental processes, a method for producing nonmosaic mutants is needed. Here, we established a method for generating non-mosaic mouse mutant embryos. We introduced Cas9 protein and sgRNA into in vitro fertilized (IVF) zygotes by electroporation, which enabled the genome editing to occur before the first replication of the mouse genome. As a result, all of the cells in the mutant carried the same set of mutations. This method solves the problem of mosaicism/allele complexity in founder mutant embryos or mice generated by the CRIPSR/Cas9 system.
Introduction
Genetically modified mice are a powerful and widely used tool for elucidating the roles of genes in development and disease. However, conventional methods involving homologous recombination in embryonic stem cells are costly and time-consuming. The development of the CRIPSR/Cas9 system dramatically improved this situation (Cong et al., 2013; Gaj et al., 2013) . Because of its high efficiency, the CRISPR/Cas9 system can elucidate the functions of genes directly in the founder generation (F0).
A common approach for generating mutant embryos or mice using the CRISPR/Cas9 system is to inject Cas9 mRNA and sgRNA, or their expression plasmid into zygotes Yang et al., 2013; Yasue et al., 2014) . Alternatively, we and other groups recently established electroporation methods for introducing Cas9 mRNA and sgRNA into zygotes (Hashimoto and Takemoto, 2015; Kaneko et al., 2014; Qin et al., 2015) . However, most of the mutants that develop from the injected or electroporated zygotes are genetically mosaic, that is, individual cells in a mutant carry different sets of insertions or deletions (indels) (Mizuno et al., 2014; Oliver et al., 2015; Yen et al., 2014) . Typically, four or more different mutant alleles are observed in a mutant, indicating that genome editing occurred after the first genome replication. This genetic mosaicism complicates the phenotype analysis. Thus, to elucidate the roles of genes in the F0 generation, a method for producing biallelic and non-mosaic mutants is needed.
In this study, we generated biallelic and non-mosaic mutant mouse embryos by transferring Cas9 protein and sgRNA into in vitro fertilized (IVF) zygotes by electroporation. This method will greatly ease studies of gene function using genome-edited F0 mice.
Material and methods

Animals
All of the animal care and experiments were carried out in accordance with the Guidelines for Animal Experiments of Tokushima University and of Osaka University, and were approved by the Ethics Committee of Tokushima University for Animal Research (Approval number: 14022) and the Animal Care and Use Committee of Osaka University (Approval number: FBS-15-001).
2.2. mCherry mRNA, sgRNA, Cas9 protein, and ssODN preparation For pCS2-mCherry plasmid construction, the coding region of mCherry cDNA was amplified by PCR using pmCherry vector (Clontech) as a template. The amplified fragment was ligated Contents lists available at ScienceDirect journal homepage: www.elsevier.com/locate/developmentalbiology Developmental Biology between BamHI and EcoRI sites of pCS2 vector. mCherry mRNA was synthesized using the mMessage mMachine SP6 Kit (Ambion) and the NotI digest of pCS2-mCherry as a template.
A pair of oligonucleotides targeting the Fgf10 or Brachyury gene was annealed and inserted into the BsaI site of the pDR274, a plasmid vector to create a sgRNA by in vitro transcription using T7 promoter (Hwang et al., 2013) . pDR274 was a gift from Dr. Keith Joung (Addgene plasmid # 42250). The target sequences were as follows: Fgf10 (5′-GGAGAGGACAAAAAACAAGA-3′), Brachyury1 (5′-TTGCGA-GACCGGTTGCCG-3′) and Brachyury2 (5′-TTAAACCCTGCCGGCATA-3′). After digestion with DraI, sgRNAs were synthesized using the MEGAshortscript T7 Transcription Kit (Ambion). The synthesized sgRNAs were purified by phenol-chloroform-isoamylalcohol extraction and isopropanol precipitation. The precipitated RNA was dissolved in Opti-MEM I (Thermo Fisher Scientific) at 2-4 mg/ml, and stored at À 20°C until use. RNAs were quantified by absorption spectroscopy and agarose gel electrophoresis. Cas9 protein was purchased as a component of the Guide-it™ Complete sgRNA Screening System (Takara Bio Inc.). The ssODNs were purchased from Sigma in dry form, dissolved in Opti-MEM I to 1 μg/ml, and stored at À20°C until use. The sequences of the ssODNs were: Fgf10XbaI (5′-TCGTCATGGGGAGGAAGTGAGCAGAGGTGTTTTTCCTTCTAGATGTTT TTTGTCCTCTCCTGGGAGCTCCTTTTCCATTCAAT-3′) and Fgf10EcoRI (5′-TGGATCGTCATGGGGAGGAAGTGAGCAGAGGTGTTTTTCCGAATTCTTGT TTTTTGTCCTCTCCTGGGAGCTCCTTTTCCATT-3′).
2.3. Mice, and egg and embryo collection and transfer B6D2F1 (C57BL/6NCr Â DBA/2Cr F1) mice were used in this study. Fertilized eggs were collected at E0.25 (8:00) from the oviducts of naturally intercrossed females. The covering cumulus cells were removed by incubation in 1% hyaluronidase/M2 medium. The fertilized eggs were incubated in KSOM medium until electroporation. IVF was performed following a standard protocol using the B6D2F1 strain (Behringer, 2014) . After a 3-h culture of oocytes and sperm, the eggs were removed from the sperm and cultured for 2 h until electroporation. The electroporated embryos were cultured in KSOM medium, and transferred next day to the oviducts of pseudopregnant females on the day of the vaginal plug (Behringer, 2014) . All the media were prepared following a standard protocol (Behringer, 2014) .
Electroporation
CUY21EDIT II or Genome Editor electroporator and LF501PT1-10 platinum plate electrode (length: 10 mm, width: 3 mm, height: 0.5 mm, gap: 1 mm) (BEX Co. Ltd., Tokyo, Japan) were used for electroporation.
The electrode was connected to the electroporator and was set under a stereoscopic microscope. 30-40 zygotes prepared by natural breeding (NB) or IVF were subjected to electroporation at one time. The collected zygotes cultured in KSOM medium were washed with Opti-MEM I three times to remove the serum in the medium, placed in a line in the electrode gap filled with 5 ml of Opti-MEM I containing mCherry mRNA or mixture of Cas9 protein and sgRNA, and subjected to electroporation. The electroporation conditions were 30 V (3 msec ON þ97 msec OFF) 7 times in most experiments. After electroporation, the zygotes were immediately collected from the electrode chamber and subjected to four washes with M2 medium followed by two washes with KSOM medium. The eggs were then cultured in KSOM medium at 37°C and 5% CO 2 in an incubator until the two-cell stage.
Fluorescent signal detection and analyses
The mCherry fluorescence of the electroprorated zygotes cultured in vitro was detected by an EM-CCD camera equipped to the inverted microscope and Nipkow-disc confocal unit. The data was analyzed using the ImageJ software. Relative fluorescent intensity was calculated as the average intensity of E0.75-EP embryos at E1.5 was regarded as 100%. Average intensity was calculated using five embryos and plotted.
Genome editing of Fgf10 and Brachyury
At the indicated time points (Fig. 2b) , 50 ng/ml Cas9 protein and 200 ng/ml sgRNAs targeting the Fgf10 or Brachyury gene were introduced into zygotes by electroporation. For the HDR-mediated knock-in study, 400 ng/ml ssODN was introduced together with Cas9 protein and sgRNA. The surviving 2-cell-stage embryos were transferred to the oviducts of pseudopregnant females on the day of the vaginal plug. The mice were dissected at E16.5 or E17.5 (Fgf10) or E9.5 (Brachyury), and the embryos were collected.
To investigate the CRISPR/Cas9-mediated mutations in the Fgf10 or Brachyury gene, genomic DNA was prepared from the yolk sac of the embryos. The genomic regions flanking the sgRNA target were amplified by PCR using specific primers: Fgf10 Fwd (5′-TGACTCTTCTGTTGTTAGCGTTG-3′) and Rev (5′-ACATC-CAAAGCCTTCCTTCC-3′), Brachyury Fwd (5′-ACTGGAATGAC-CAGGTTTGC-3) and Rev (5′-CTGCTTCCCACAGATGGTCT-3′). The PCR amplicons of Fgf10 or Brachyury were cloned into the pMD20 (Takara Bio Inc.) vector. More than ten plasmids for each embryo were isolated, and the genomic region was sequenced. Sequencing was performed using the BigDye terminator Cycle Sequencing Kit ver. 3.1 and the ABI 3500 Genetic Analyzer (Applied Biosystems).
Deep-sequencing analysis
Fgf10 and Brachyury target sites were amplified from the genomic DNA extracted from entire embryos. The PCR amplicons were sequenced using the MiSeq Reagent Kit Nano v2 (500 cycles) and the MiSeq sequencer (Illumina). MiSeq reads were analyzed using Excel software.
Immunostaining
The immunostaining was done as described previously (Takemoto et al., 2011) . The embryos were fixed overnight with 4% PFA in PBS, immersed in 15% and 25% sucrose in PBS in sequence for 2 h each step, and embedded in OCT compound. Cryosections with thickness of 10 mm were prepared, and treated at 105°C for 15 min in antigen unmasking solution (Vector Laboratories) using an autoclave. The sections were reacted with 10% normal donkey serum for 30 min, then with the goat anti-Sox2 antibody (AF2018, R&D Systems) at 1:200 dilutions overnight at 4°C. After several washes, the sections were incubated with Alexa Fluor 488-labelled antigoat IgG (A-11055, Molecular Probes) secondary antibody at 1:200 dilutions for 1 h at ambient temperature. After several washes the samples were stained with 0.5 mg/ml Hoechst 33342, and mounted in Permafluor (Thermo Fisher Scientific). Fluorescence images were taken using a DMI4000B inverted microscope (Leica Microsystems) with an ORCA-Flash4.0 V2 sCMOS camera (Hamamatsu Photonics).
Results
Translation of exogenously introduced mRNA in zygotes occurs after the first genome replication
Mutant embryos or mice are usually generated with the CRISPR/Cas9 system by introducing Cas9 mRNA and sgRNA into zygotes by microinjection or electroporation. To generate a nonmosaic mutant, the introduced Cas9 mRNA needs to be translated and functional before the first replication of the genome. To investigate when the exogenously introduced mRNA is translated into a functional protein in zygotes, we electroporated mCherry mRNA into zygotes at various time points during the pronuclear stage, and monitored the fluorescence of the zygotes (Fig. 1) . Regardless of the timing of electroporation, the fluorescence of the mCherry protein increased after E0.8 and plateaued around E1.3, indicating that the translational machinery was fully activated after E0.8. Since most zygotes enter the genome replication phase before E0.8, the introduction of Cas9 mRNA into early pronuclear zygotes by electroporation would not generate non-mosaic mutants.
Therefore, for immediate genome editing and the generation of non-mosaic mutants, we next sought to introduce Cas9 protein into early pronuclear stage zygotes.
Electroporation of Cas9 protein into early pronuclear stage zygotes produces biallelic and non-mosaic Fgf10 mutants
We next examined whether the electroporation of Cas9 protein and sgRNA into early pronuclear stage zygotes would generate non-mosaic mutant embryos. Early pronuclear zygotes were prepared by IVF (IVF zygotes). We cultured freshly prepared eggs with sperm for 3 h, and then removed the sperm and cultured the eggs for 2 h until electroporation (Fig. 2b) . For comparison, we prepared zygotes in vivo by natural breeding (NB zygotes). The IVF or NB zygotes were electroporated with 50 ng/ml nuclear localization signal (NLS)-tagged humanized Streptococcus pyogenes Cas9 (hereafter Cas9) protein and 200 ng/ml sgRNA targeting the Fgf10 gene 5 h after the initiation of IVF or at E0.5 (12 h after the midpoint; 22 h after hCG injection) (Fig. 2a,b) . We also electroporated the NB embryos with 400 ng/ml Cas9 mRNA and 200 ng/ml sgRNA (Hashimoto and Takemoto, 2015) . The electroporated zygotes that developed to the 2-cell stage were transferred into pseudopregnant females, and the embryos were analyzed at E16.5 or E17.5.
The resulting mutant embryos were classified according to the severity of the limb defect ( Fig. 2c) : type I embryos developed with no fore-or hindlimbs, which is the same as Fgf10 homozygous mutant embryos. Type II embryos exhibited a milder phenotype than type I: embryos with forelimbs but no hindlimbs or embryos with truncated forelimbs (Hashimoto and Takemoto, 2015) . Most of the embryos (16 out of 17 embryos [94%] ) that developed from the electroporated IVF or NB zygotes exhibited the type I phenotype (Fig. 2d) . In addition to limb defects, these embryos also lacked lungs. Since the limbless and no lung phenotype (type I) is not observed in Fgf10 heterozygotes, these results indicated that the embryos carried a bi-allelic mutation in the Fgf10 gene.
We next analyzed the genomic sequence of the type I embryos (Table 1 ). The genomic sequence flanking the sgRNA target site was amplified by PCR and subcloned. More than ten clones from each embryo were analyzed. All of the clones from either the IVF embryos or the NB embryos carried indels, and no wild-type sequence was detected, confirming the bi-allelic mutation. Importantly, all of the IVF embryos carried one or two types of indels (3/10 or 7/10, respectively), whereas most of the NB embryos carried three (7/12) (Fig. 2e,Table 1 ). NB embryos electroporated with 400 ng/ml Cas9 mRNA and 200 ng/ml sgRNA carried four types of indels in most case (5/8) (Hashimoto and Takemoto, 2015) . We also analyzed the genomic sequence of six IVF embryos using deep-sequencing. The majority of the target sequences of IVF embryos carried the indels which were detected in the cloning analysis (Table 1 ). The remainings were the mixture of various sequences, each of which accounted for less than 5% of the total sequence number. These sequences were also detected at the same proportion (30% of total sequence, each sequence was less than 5%) in the wild-type embryos, and therefore were expected to be the PCR and/or sequence error. There was no difference in the genome editing efficiency or survival rate of embryos between the IVF and the NB zygotes (Fig. 2d) . These results indicated that the genome editing occurred before the first genome replication in the IVF embryos, and that the IVF embryos were non-mosaic, carrying the same set of mutations in all of the cells (Fig. 2e,Table 1 ).
Homology-directed repair (HDR)-dependent knock-in of exogenous DNA into the target locus
We next examined whether exogenous DNA could be incorporated into the mouse genome via homology-directed repair (HDR) before the first genome replication. For this experiment, we sought to introduce an XbaI restriction enzyme recognition site into the sgRNA target region of the Fgf10 gene. A single-stranded oligodeoxynucleotide (ssODN) harboring an XbaI site flanked by 40 base-long homology arms was introduced with Cas9 protein and sgRNA into IVF zygotes by electroporation (Fig. 3a , Supplementary Table 1 ). The electroporated embryos were transferred into pseudopregnant females the next day and dissected at E16.5. Most of the embryos (7/9) developed without limbs (type I mutants). The sgRNA target region was amplified from each embryo by PCR, and treated with XbaI. Four of the nine embryos were positive for XbaI digestion (Fig. 3b) . For these four embryos, the sequence analysis of each fragment revealed only two types of mutations in each embryo: one carrying the knocked-in XbaI site and the other the indel mutation (Fig. 3c) . We also introduced an EcoRI restriction enzyme site into the Fgf10 gene ( Supplementary  Fig. 1, Supplementary Table 1) . These results together indicated that the HDR-mediated knock-in of an exogenous sequence also occurred before the first genome replication.
Generation of Brachyury mutant embryos by exon deletion
Next, we sought to generate Brachyury mutant embryos by exon deletion. Brachyury encodes a member of the T-box family of transcription factors and is involved in the regulation of mesoderm development early in embryogenesis (Herrmann and Kispert, 1994; Kispert and Hermann, 1993) . In Brachyury mutant embryos, ectopic neural tube(s) form immediately ventral to the normal neural tube (Yamaguchi et al., 1999) .
To inactivate the Brachyury function, we sought to delete the second exon, which encodes the T-box DNA-binding domain, from the mouse genome (Fig. 4a) . We prepared two sgRNAs, sgRNA1 and 2, which target the upstream and downstream regions of the second exon of the Brachyury gene, respectively. We then electroporated IVF zygotes with 50 ng/ml of each sgRNA and 50 ng/ml Cas9 protein. The embryos were transferred into pseudopregnant females the next day, and then analyzed at E9.5. All of the embryos exhibited a phenotype identical to that of Brachyury mutants, namely the development of ectopic neural tubes and truncation of the posterior axis (Fig. 4b,c) .
To analyze the genomic sequence of the Brachyury gene, genomic DNA was extracted from the tail of the embryos, and amplified by PCR (Fig. 4d) . Two primers designed to amplify the second exon normally produce a 1.2-kb product. However, a 200- base product was amplified from the electroporated embryos, indicating that the second exon was deleted from the mouse genome. Sequence analysis of the PCR amplicons revealed that a 1.0-kb genomic region including the second exon was deleted ( Table 2) . As in the case of the Fgf10 gene editing, individual Brachyury mutant embryos carried only one or two types of ctcccaGGAGAGGACA-----------aaaaacacctctg 13 bp deletion 5/9
Embryo #8 ctcccaGGAGAGGACAAAAAACA-GAAGGaaaaacacctctg 1 bp deletion 9/11
ctcccaGGAGAGGACAAAA------GGaaaaacacctctg 8 bp deletion 2/11 ctcccaGGAGAGGACAAAAA-------------acctctg 15 bp deletion 3/12
ctcccaGGAGAGGACAAAAA-----GGaaaaacacctctg 7 bp deletion 1/10
Embryo #8
ctcccaGGAGAGGACAAAAAACA-----------cctctg 13 bp deletion 5/11 mutations, indicating that the genome editing occurred before the first genome replication (Fig. 4e, Table 2 ).
Discussion
Introduction of Cas9 mRNA and sgRNA into zygotes generates mosaic mutants
The first widely used method for generating mutant mice with the CRISPR/Cas9 system was the microinjection of Cas9 mRNA and sgRNA into mouse zygotes. Recently, we and other groups established electroporation methods for introducing the Cas9 mRNA and sgRNA into mouse zygotes (Hashimoto and Takemoto, 2015; Kaneko et al., 2014; Qin et al., 2015) . The mutants generated using these methods are often mosaic, composed of several types of cells with different mutations. This genetic mosaicism may result from the occurrence of genome editing after the first replication of the zygotic genome. In the mouse, the first genomic DNA replication in the zygote starts 20 h after the administration of hCG, which normally corresponds to around E0.4 (10 h after the midpoint) (Adenot et al., 1997; Aoki et al., 1997) . In our previous study, the Cas9 mRNA was electroporated into mouse zygotes at E0.5 or later, so genome editing was expected to occur after the translation of Cas9 mRNA to protein and after the first genome replication. Consistent with this scenario, four or more types of indels were detected in each mutant (Hashimoto and Takemoto, 2015) . Thus, to generate non-mosaic mutants, the Cas9 protein needs to be functional prior to the genome replication in 1-cell zygotes. However, the translational machinery appeared to be most highly activated after E0.8, when most zygotes enter the genome replication phase. This result indicated that, even if we introduced the Cas9 mRNA into very early-stage zygotes by either electroporation or microinjection, the generated mutants would be still mosaic.
Electroporation of Cas9 protein into early pronuclear zygotes generates non-mosaic mutant mouse embryos
Recently, Cas9 protein/sgRNA was introduced into mouse zygotes by microinjection (Aida et al., 2015; Sung et al., 2014) . In zebrafish, the injection of Cas9 protein/sgRNA at the 1-cell stage decreased mosaicism (Burger et al., 2016) , indicating that the use of Cas9 protein/sgRNA is applicable to decrease mosaicism in mice. However, the use of NB zygotes still resulted in the generation of mosaic mutants (Sung et al., 2014) . We reason that this mosaicism occurred because the authors used zygotes prepared from naturally breeding female mice, and these zygotes developed to S-phase when Cas9 protein and sgRNA were introduced. We hypothesized that introduction of Cas9 protein/sgRNA into earlystage zygotes could generate non-mosaic mutants. To prepare early-stage zygotes, we used IVF, a common and well-established technique that enables researchers to control the fertilization timing and to prepare a large number of developmentally synchronized zygotes. As a result, we successfully generated mutant embryos carrying only one or two types of indels, indicating that genome editing occurred before the first genome replication. On the other hand, when we performed the electroporation using zygotes from naturally breeding female mice at E0.5, most of the mutant embryos were mosaic, carrying three types of indels, indicating that genome editing occurred during the first replication of the mouse genome.
4.3. HDR-mediated knock-in of an exogenous sequence into the premitotic 1-cell zygotic genome
In general, non-homologous end joining (NHEJ) dominates over HDR in the DNA repair after the double strand break caused by Cas9 (Lieber, 2010; Mao et al., 2008) , so the mosaic mutants generated by Cas9 mRNA transfer are composed of a large population of cells with NHEJ-mediated indels and a small population with HDR-mediated knock-in. To study the effect of a knock-in, we need to generate offsprings carrying the knock-in mutation; however, it is impossible to know in advance whether a desired knock-in mutation, and not other indel mutations, in F0 mosaic mice, will be carried by the germ line and inherited by the next generation.
In this study, we generated mutant embryos carrying the knock-in of an exogenous sequence at a comparable rate (N ¼4/9) to that achieved with Cas9 mRNA electroporation (N ¼4/10 in Hashimoto and Takemoto (2015) ). Furthermore, these embryos generated in this study were non-mosaic knock-in mutants. The knock-in allele would be carried by the germ cells and inherited by the next generations.
Advantages of Cas9 protein electroporation method
NLS-tagged Cas9 proteins are commercially available from various suppliers, saving the time needed to synthesize Cas9 mRNA in vitro. Cas9 without an NLS can be used, but its efficiency for genome editing was lower than that with NLS (data not shown). Recently, chemically synthesized CRISPR RNA (crRNA) and trans-activating CRISPR RNA (tracrRNA) were used as a substitute for sgRNA, and injected with Cas9 protein into mouse zygotes (Aida et al., 2015) . The crRNA and tracrRNA could be used in our electroporation method, eliminating the need for laborious molecular biology steps such as RNA preparation.
In this study, we generated non-mosaic mutants by electroporating Cas9 protein and sgRNA into early-stage zygotes. Because the time window between fertilization and the first DNA replication is limited, time-consuming microinjection is not suitable for this purpose. Microinjection requires special skill, and even with such ability, handling of two hundred zygotes requires more than two hours. Our electroporation method does not require such skills and can introduce Cas9 protein and sgRNA into two hundred zygotes in less than 30 min, thus enabling hundreds of zygotes to be treated before the first genome replication.
Although our new method is powerful when we consider analyzing the roles of genes in the F0 embryos, it is not suitable for generating breedable mouse lines of lethal genes. For the latter purpose, heterozygous and/or mosaic mutants carrying wild-type genes are required. Genome editing efficiency depends on the concentration of Cas9 protein introduced into zygotes, so electroporation of the reduced concentration of Cas9 protein may generate heterozygous mutant mice carrying intact wild-type sequence. In fact, in our earlier study, electroporation of the reduced concentration of Cas9 mRNA and sgRNA generated mosaic mutant embryos carrying wild-type sequences (Hashimoto and Takemoto, 2015) . Researchers can choose an appropriate method depending on their purpose.
In this study, we introduced small exogenous sequences into the target sites using ssODN. By co-electroporating a plasmid harboring long exogenous reporter gene such as GFP, instead of an ssODN, a variety of reporter mice would be rapidly generated.
In conclusion, we demonstrated that introduction of Cas9 protein and sgRNA into IVF zygotes by electroporation enabled the introduction of a mutation, either via NHEJ-mediated indels or HDR-mediated knock-in, before the first DNA replication, and thus the generation of mutant mice with low mosaicism. Our electroporation method will be useful for generating genetically modified mice for a wide range of biological and medical research projects.
